Markets opened today’s session trading on yesterday’s sagging momentum, but major indexes have recovered their bullish pace this afternoon, advancing to solid gains.

Extremely strong consumer confidence numbers, bolstered by a favorable US home price report, sent the markets shooting out of their brief doldrum.

Today, we take a look at some of the top “Analyst Actions” available to NewsQuantified users. We rate the most prominent financial analysts around the globe and let you know when they change their rating/price target on a given stock.

What’s more, we provide data that shows our users how often the rating changes issued by a given analyst result in a “win:” price movement in the predicted direction.

Our Win% metrics let you quickly sort through the chatter to focus on analysis from financial professionals who consistently get it right.

Today’s Analyst Action, for instance, comes from Cowen Capital, which wins on an astonishing 74% of its rating changes.

Emerson Electric (EMR): Upgraded by Cowen Capital.

This morning, Cowen Capital announced that they were upgrading Emerson Electric, and raising their price target on the stock from $61 to $71. Emerson is a US Electric Utility company.

The move comes largely due to Cowen’s approval of a strategic shift by Emerson. EMR will no longer be pursuing the hostile takeover of Rockwell Automation (ROK). Cowen’s analysis group believes that the takeover bid would have weighed down Emerson’s balance sheet with subpar earnings. Furthermore, M&A activity was creating price churn obscuring the value of EMR, analysts assert, by adding an element of speculation to an electric utility stock—traditionally a value play.

They see higher, less cyclically exposed returns in the future now that Emerson is exploring alternative capital growth strategies.

The stock has had a muted reaction to the ratings change so far, up less than 1%, suggesting substantial upside may remain.

Diverse Plays, Great Profits: All in a single news day.

Keep checking our blog for daily updates on lucrative new-based stock plays, analyst actions, and more!

We analyze news events ranging from clinical trials in the pharmaceutical industry to routine earnings releases to major geopolitical shakeups.

Or, if you’re ready to move beyond the blog and experience the power of hedge-fund caliber news analysis in a package that’s accessible to small investors, click here to sign up for a free training today. You’ll see how easy to use our platform really is—and how many profitable trades it can unlock

A powerful news analytics platform like NewsQuantified not only makes it easy to track the news, but to quickly compare news events with key financial information. We make it simple to find strong, diverse plays in any market environment.

How are you using the news to earn market-beating profits? How would you use the news if you had access to a real-time platform like NewsQuantified?  Let us know in the comments below.

Leave a comment